Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: count gold who wrote (182)	11/10/1997 12:34:00 PM
From: majormember	Read Replies (1) \| Respond to of 4140

Nanny, I got an e-mail back from a Dr. Rasheed (RASHEEDK@CSMC.EDU) on the Sunrise LTK when I inquired as to his knowledge of it: "It is my understanding that LTK is not very useful for the treatment of hyperopia beyond 3 or 4 diopters. It is also associated with a high regression rate. The excimer laser (VISX) is in FDA trails for the treatment of hyperopia and initial results indicate that the treatment of up to +4 diopters can be done reliably and with little regression." My understanding was LTK had a much lower regression rate than excimer. ANY COMMENTS ON RESPONSE FROM DR. RASHEED? Skane